β¨ Medicines Act Notice
SUPPLEMENT TO
New Zealand Gazette
OF THURSDAY, 20 JULY 2006
WELLINGTON: FRIDAY, 21 JULY 2006 β ISSUE NO. 83
Departmental Notice
Health
Medicines Act 1981
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: MeNZB
Active Ingredient: Neisseria meningitidis group B (strain NZ98/254) 25Β΅g/dose
Dosage Form: Suspension for injection
New Zealand Sponsor: Medconsult Services Limited
Manufacturer: Chiron S.r.l, Bellaria, Rosia, Sovicille, Italy
Note: This consent is valid for two years from 8 July 2006.
Dated this 19th day of July 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go4970
PUBLISHED BY THE
DEPARTMENT OF INTERNAL AFFAIRS
PRINTED BY WICKLIFFE LIMITED
ISSN 0111-5650
Price $1.60 (inc. G.S.T.)
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 83
Gazette.govt.nz —
NZ Gazette 2006, No 83
β¨ LLM interpretation of page content
π₯ Renewal of Provisional Consent for MeNZB Medicine
π₯ Health & Social Welfare19 July 2006
Medicines Act, Provisional Consent, MeNZB, Vaccine, Distribution
- DON MATHESON, Deputy Director-General, Public Health